Outcome of allogeneic haematopoetic stem cell transplantation for patients with primary or secondary resistance to imatinib in chronic myeloid leukaemia

被引：0
作者：
Koldehoff, M [1 ]
Elmaagacli, AH [1 ]
Steckel, NK [1 ]
Hlinka, M [1 ]
Ditschkowski, M [1 ]
Trenschel, R [1 ]
Peceny, R [1 ]
Beelen, DW [1 ]
机构：
[1] Univ Hosp, Essen, Germany
来源：
BONE MARROW TRANSPLANTATION | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S236 / S236
页数：1
相关论文
共 50 条
  • [21] Secondary malignancy post allogeneic stem cell transplant for chronic myeloid leukaemia
    Dannie, E
    Szydlo, R
    BONE MARROW TRANSPLANTATION, 2002, 29 : S280 - S280
  • [22] Impact of primary disease on outcome after allogeneic stem cell transplantation for transformed secondary acute leukaemia
    Kroeger, Nicolaus
    Eikema, Diderik-Jan
    Koster, Linda
    Beelen, Dietrich
    de Wreede, Liesbeth C.
    Finke, Juergen
    Koenecke, Christian
    Niederwieser, Dietger
    Bornhaeuser, Martin
    Schoenland, Stefan
    Potter, Victoria
    Wolschke, Christine
    Maertens, Johan
    Theobald, Matthias
    Kobbe, Guido
    Itala-Remes, Maija
    Wulf, Gerald
    Kahls, Peter
    Forcade, Edouard
    Greinix, Hildegard
    Masszi, Tamas
    Yakoub-Agha, Ibrahim
    Chalandon, Yves
    Robin, Marie
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (04) : 725 - 732
  • [23] Non-myeloablative stem cell transplantation with imatinib for chronic myeloid leukaemia in chronic phase
    Luo, Y.
    Huang, H.
    Tan, Y.
    Han, X.
    Zhu, X.
    Lai, X.
    Cai, Z.
    Lin, M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S438 - S438
  • [24] Imatinib mesylate therapy in patients with chronic myeloid leukaemia previously treated with autologous stem cell transplantation
    Cortés, M
    Sureda, A
    Martino, R
    Aventin, A
    Nomdedeu, J
    Briones, J
    Valcárcel, D
    Brunet, S
    Sierra, J
    BONE MARROW TRANSPLANTATION, 2004, 33 : S151 - S151
  • [25] Outcome of allogeneic hematopoietic stem cell transplantation for pediatric patients with chronic myeloid leukemia
    Kennedy-Nasser, A. A.
    Arce, J.
    Leung, K. S.
    Gottschalk, S.
    Bollard, C. M.
    Heslop, H. E.
    Brenner, M. K.
    Krance, R. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 92 - 93
  • [26] Imatinib Mesylate Versus Allogeneic Hematopoietic Stem Cell Transplantation For Patients With Chronic Myeloid Leukemia In Chronic Phase
    Liu Xiaoli
    Gao, Guanlun
    Zhou, Xuan
    Xu, Na
    Xiao, Yajuan
    Cao, Rui
    Yin, Changxin
    Zhou, Hongsheng
    Wei, Yongqiang
    Zhang, Yu
    Xu, Dan
    Xu, Bing
    Feng, Ru
    Liu, Qifa
    Sun, Jing
    Meng, Fanyi
    BLOOD, 2013, 122 (21)
  • [27] Impact of cytogenetics on outcomes of patients with secondary acute myeloid leukaemia undergoing allogeneic stem cell transplantation
    Lim, Z. Y.
    Brand, R.
    Biezen, A.
    Beelen, D. W.
    Devergie, A.
    Alessandrino, E.
    Sierra, J.
    Ruutu, T.
    Falda, M.
    Jouet, J.
    Niederwieser, D.
    Mufti, G.
    de Witte, T.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S63 - S63
  • [28] Clinical characteristics and outcome of patients relapsing 2 years or more following allogeneic stem cell transplantation for chronic myeloid leukaemia
    Sipavicius, J.
    Szer, J.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S352 - S353
  • [29] Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia
    Olavarria, E
    Ottmann, OG
    Deininger, M
    Clark, RE
    Bandini, G
    Byrne, J
    Lipton, J
    Vitek, A
    Michallet, M
    Siegert, W
    Ullmann, A
    Wassmann, B
    Niederwieser, D
    Fischer, T
    LEUKEMIA, 2003, 17 (09) : 1707 - 1712
  • [30] Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia
    A Bacigalupo
    Leukemia, 2003, 17 : 1722 - 1722
12345